Literature DB >> 7286897

Urinary coproporphyrin isomers in Rotor's syndrome: a study in eight families.

Y Shimizu, H Naruto, S Ida, M Kohakura.   

Abstract

Urinary coproporphyrin isomers were measured in 17 patients with Rotor's syndrome, 65 phenotypically normal relatives of 14 patients from eight families, and 21 normal subjects. coproporphyrin I was elevated in Rotor's syndrome (p less than 0.001) and, to a lesser degree, in phenotypically normal parents (p less than 0.005), children, and siblings (p less than 0.025) as compared to normal controls. Coproporphyrin III in patients, parents, and children did not differ from that in normal controls. Genetic analysis was consistent with transmission of Rotor's syndrome as an autosomal recessive trait with respect to urinary excretion of coproporphyrin I. After i.v. injection of delta-aminolevulinic acid, urinary coproporphyrin I increased to a similar extent in Rotor's syndrome and in normal subjects; urinary coproporphyrin III excretion was less in Rotor's syndrome than in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286897     DOI: 10.1002/hep.1840010214

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  [Renal and enteral elimination of coproporphyrin isomers in Rotor's syndrome. A family study].

Authors:  H Kellner; W G Zoller; K Jacob; H S Füessl
Journal:  Klin Wochenschr       Date:  1988-10-03

2.  Porphyrin metabolism and haem biosynthesis in Gilbert's syndrome.

Authors:  K E McColl; G G Thompson; E el Omar; M R Moore; A Goldberg
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

3.  Clinical Investigation of Coproporphyrins as Sensitive Biomarkers to Predict Mild to Strong OATP1B-Mediated Drug-Drug Interactions.

Authors:  Annett Kunze; Emmanuel Njumbe Ediage; Lieve Dillen; Mario Monshouwer; Jan Snoeys
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

Review 4.  Gene replacement therapy for genetic hepatocellular jaundice.

Authors:  Remco van Dijk; Ulrich Beuers; Piter J Bosma
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 5.  Neonatal Cholestasis - Differential Diagnoses, Current Diagnostic Procedures, and Treatment.

Authors:  Thomas Götze; Holger Blessing; Christian Grillhösl; Patrick Gerner; André Hoerning
Journal:  Front Pediatr       Date:  2015-06-17       Impact factor: 3.418

6.  Quantitative Prediction of OATP-Mediated Drug-Drug Interactions With Model-Based Analysis of Endogenous Biomarker Kinetics.

Authors:  Kenta Yoshida; Cen Guo; Rucha Sane
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-08-23

7.  Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers.

Authors:  Sook Wah Yee; Marilyn M Giacomini; Hong Shen; W Griffith Humphreys; Howard Horng; William Brian; Yurong Lai; Deanna L Kroetz; Kathleen M Giacomini
Journal:  Clin Transl Sci       Date:  2019-04-13       Impact factor: 4.689

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.